Two U.S. women have filed Zofran lawsuits that allege heart defects born to their children, who were exposed to the medication in the womb, court documents indicate.
According to recent reports, one complaint was filed February 12th in the U.S. District Court, Eastern District of Pennsylvania by a woman who gave birth to two babies, one in 2004 and the other 2006, both with congenital heart defects. The Massachusetts mother had been taking Zofran, an anti-nausea drug that is approved for use in chemotherapy and surgery patients but is often prescribed to treat morning sickness, during both pregnancies, her lawsuit alleges.
The plaintiff in another case, which was filed February 16th in the District of Minnesota, also alleges Zofran heart defects. Her daughter was also born with congenital malformations and other issues that followed exposure to the drug, which is manufactured by GlaxoSmithKline, according to claims. The child has since undergone at least thirteen surgeries to correct birth defects allegedly caused by Zofran, which her mother took during the first trimester of pregnancy.
Both of these lawsuits allege that GlaxoSmithKline knew about the drug’s association with birth defects, and have conducted multiple studies that proved it. Before Zofran’s U.S. approval in 1991, its manufacturers found evidence that it may cross with the placenta—meaning that the infant would feel the drug’s effects in some way. Glaxo insisted at the time that this connection did not translate to an increased risk of birth defects. Since then, instances of Zofran cleft lip and palate defects, as well as other problems have been reported.
The company itself has also received numerous birth defect reports since 2000, 32 of which noted kidney defects, stillborn deaths and congenital heart disease, according to Zofran lawsuits.
“In many instances, GSK received multiple reports i the same month, the same week and even the same day,” claimants assert.
Attorneys for the Zofran plaintiffs go on to note a specific instance where GlaxoSmithKline received several side effect reports related to the medication. “For example, on or about September 13, 2000, GSK received three separate reports involving Zofran use and adverse events. For two of those incidents, the impact on the baby was so severe that the baby died,” their complaint alleges.
The attorneys at Bernstein Liebhard LLP are investigating potential Zofran lawsuits that allege serious birth defects caused by the morning-sickness medication. By filing a claim against GlaxoSmithKline, you may be eligible to receive compensation for out-of-pocket medical expenses, lost wages and other damages that allegedly resulted from use of Zofran. Call us now at (888) 881-3077.